Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo

Medicin og biovidenskab

• Acetylation 10%
• Anti-Idiotypic Antibodies 8%
• B-Cell Lymphoma 10%
• Biopsy 5%
• Blood Cells 8%
• Cell Line 5%
• Clinical Trials, Phase I 11%
• Convulsive Therapy 29%
• Cyclophosphamide 9%
• Doxorubicin 9%
• Drug Therapy 11%
• Epigenomics 25%
• Histone Deacetylase Inhibitors 23%
• In Vitro Techniques 4%
• Lymphoma 24%
• Lymphoma, Large B-Cell, Diffuse 100%
• Membrane Proteins 8%
• Messenger RNA 5%
• Monoclonal Antibodies 7%
• Neoplasms 3%
• Prednisone 10%
• Rituximab 21%
• Therapeutics 12%
• Up-Regulation 64%
• Valproic Acid 97%
• VAP-cyclo protocol 15%
• Vincristine 10%